openPR Logo
Press release

Global Human Recombinant Insulin Market – Industry Insights

09-06-2018 03:09 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Human Recombinant Insulin Market – Industry Insights

Discovery of insulin is considered to be one of the most important events in the history of the diabetes treatment. Furthermore, major advances in human insulin technology is the synthesis of human insulin analogue by recombinant technology. Currently, human insulin delivery system available for the administration of insulin include insulin syringes, insulin pumps, jet injections, and pens. Key players are focused on developing recombinant human insulin instead of animal-based insulin, owing to increasing demand for human insulin in the treatment of diabetes. Human recombinant insulin has a faster onset of action and lower immunogenicity than pork or beef insulin. Currently human recombinant insulin is gaining significant traction with the development of biosimilar analogue of human insulin.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1797

According to the Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS): 2016 report, the insulin market including human recombinant insulin largely contributes around 40 local manufacturers, with largely local markets apart from three largest global insulin manufactures: Novo Nordisk A/S, Sanofi S.A. and Eli Lilly and Company. Furthermore, various manufacturers offer a recombinant analog of human insulin-like growth factor that has been specifically engineered for the research and industrial cell culture market, providing a consistent, compliant, and reliable alternative to recombinant insulin. Such manufacturers include: Merck KGaA, Thermo Fisher Scientific, Inc., among others. These manufacturers offers recombinant human insulin analogue products as a raw material or blended with custom media formulations for small scale process development and commercial biomanufacturing applications. Launch of biosimilar and other insulin products and research for recombinant insulin products is expected to drive growth of the market during the forecast period.

Moreover, rising diabetes population, worldwide combined with increasing research and development (R&D) activities by various government and private organizations in human insulin development is expected to boost growth of the human recombinant insulin market in the near future.

The global human recombinant insulin market was valued at US$ 27.4 billion in 2018, and is expected to witness a CAGR of 7.2% over the forecast period (2018 – 2026).

Click To Reading More On
https://www.coherentmarketinsights.com/market-insight/human-recombinant-insulin-market-1797

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Human Recombinant Insulin Market – Industry Insights here

News-ID: 1224881 • Views: 318

More Releases from Coherent Market Insights

Semiconductor Assembly and Testing Services Market Analysis and Forecast 2020: B …
Don’t Quarantine Your Research, you keep your social distance and we provide you a social DISCOUNT use QUARANTINEDAYS Code in precise requirement and Get FLAT 1000USD OFF on all CMI reports Market Overview Semiconductors are special type of material that have value conductivity between a conductor and an insulator. Contrary to metals, a semiconductor material’s resistance falls as its temperature increases. Semiconductor industry is highly volatile in nature. Major companies emphasize designing
CMOS Power Amplifier Market Analysis and Forecast 2020: By Keyplayers CMOS power …
Don’t Quarantine Your Research, you keep your social distance and we provide you a social DISCOUNT use QUARANTINEDAYS Code in precise requirement and Get FLAT 1000USD OFF on all CMI reports Market Overview A power amplifier is an electronic device designed to increase magnitude of power of the input signal. The power of the input signal is increased to level that can drive loads of output devices such as radiofrequency transmitters, speakers,
Remote Patient Monitoring Devices Market to Surpass US$ 1.7 Billion by 2027
A new research document with title 'Remote Patient Monitoring - Healthcare Industry Pipeline Assessment, 2020' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors such as Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic PLC., Nihon Kohden, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., and St. Jude Medical. The report will help user gain market insights, future
Sterile Injectables Market to Surpass US$ 673.8 Billion by 2027
A new research document with title 'Sterile Injectables - Healthcare Industry Pipeline Assessment, 2020' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors such as Baxter International Inc., AstraZeneca plc, Merck & Co., Inc, Novartis AG, Johnson & Johnson Services, Inc., Gilead Sciences, Inc., JHP Pharmaceuticals, Pfizer Inc., Fresenius Kabi Ag, CordenPharma, and Hikma Pharmaceuticals PLC. The report will help

All 5 Releases


More Releases for Human

Human Physiology 2019
Human Physiology 2019 Theme: Exploring the Principles of Physiology & Metabolism September 16-17, 2019 | London, United Kingdom Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
metamorphis the Human Story
contact: Rosalyn Lifshin, Executive Director Ocean City Arts Center, rozl@oceancityartscenter.orgCo (609) 399-7628
Human Resources or Human Capital?
Are people really an organisation's most important asset? Not necessarily. Some are liabilities – but some undoubtedly are the most important drivers of value that an organisation has. The question is – who are they? How do we know? How can we maximise the value they have and the value they provide? These questions are what human capital management is about. This book explains the answers and discusses approaches